A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/7088 (2006.01) A61K 31/739 (2006.01) A61K 38/05 (2006.01) A61K 38/08 (2006.01) A61P 1/06 (2006.01)
Patent
CA 2699190
The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
La présente invention concerne l'utilisation d'un agoniste du TLR9 et/ou d'un antagoniste du TLR4 et/ou d'un agoniste du NOD2 pour le traitement ou la prévention de troubles impliquant l'activation du TLR4, tels qu'une sepsie systémique et une entérocolite nécrosante.
Ducruet Alexander P.
Gribar Steven C.
Hackam David J.
Richardson Ward M.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
University Of Pittsburgh - Of The Commonwealth System Of Higher
LandOfFree
Use of toll-like receptor-9 agonists, toll-like receptor-4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of toll-like receptor-9 agonists, toll-like receptor-4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of toll-like receptor-9 agonists, toll-like receptor-4... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2021053